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Cysteine string proteins (CSPs) belong to the DnaJ-like chaperone family and play an important role in regulated exocytosis in neurons and
endocrine cells. The palmitoylation of several residues in a cysteine string domain may anchor CSPs to the exocytotic vesicle surface and in
pancreatic β-cells, Cspα is localized on insulin containing large dense core vesicles (LDCVs). An isoform closely related to Cspα, Cspβ, has been
obtained from testis cell cDNA libraries. To gain insights on this isoform and more generally on the properties of CSPs, we compared Cspα and
Cspβ. In pull-down experiments, Cspβ was able to interact to the same extent with two of the known Cspα chaperone partners, Hsc70 and SGT.
Upon transient overexpression in clonal β-cells, Cspβ but not Cspα was mainly produced as a non-palmitoylated protein and mutational analysis
indicated that domains distinct from the cysteine string are responsible for this difference. As Cspβ remained tightly bound to membranes,
intrinsic properties of CSPs are sufficient for interactions with membranes. Indeed, recombinant Cspα and Cspβ were capable to interact with
membranes even in their non-palmitoylated forms. Furthermore, overexpressed Cspβ was not associated with LDCVs, but was localized at the
trans-Golgi network. Our results suggest a possible correlation between the specific membrane targeting and the palmitoylation level of CSPs.
© 2006 Elsevier B.V. All rights reserved.Keywords: Chaperone; Exocytosis; Pancreatic β-cell; Cysteine string protein; Palmitoylation; Protein–membrane association1. Introduction
The hormone insulin is stored in large dense core vesicles in
pancreatic β-cells and released by exocytosis, a tightly
controlled phenomenon [1]. The core machinery of exocytosis
is composed of the SNARE complex, formed by Syntaxin1A,
VAMP2-Synaptobrevin, and SNAP25 [2]. Regulated exocyto-
sis implies structural rearrangement for assembly and disas-
sembly of different protein complexes, and thus requires
chaperone activity to proceed [3]. Among chaperone proteins,Abbreviations: CSP, cysteine string protein; LDCV, large dense core
vesicles; SLMV, synaptic-like microvesicles; SNAP25, synaptosome associated
protein of 25 kDa; SNARE, soluble NSF-attachment receptor; VAMP, vesicle
associated membrane protein; Hsc70, heat-shock cognate protein of 70 kDa;
SGT, small-glutamine-rich tetratricopeptide repeat (TPR)-containing protein;
TGN, trans-Golgi network
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doi:10.1016/j.bbamcr.2006.08.054Cysteine-string proteins (CSPs) have been proposed to act as
bona fide folding catalysts during late stages of insulin secretion
and also in neuroexocytosis [4–7]. Together with SGT proteins
(small-glutamine-rich tetratricopeptide repeat (TPR)-containing
protein), CSPs regulate the Hsc70 chaperone. For instance, the
trimeric complex Cspα/Hsc70/SGT has been characterized as a
chaperone complex functionally important in neurotransmission
[8,9].
CSPs were discovered as presynaptic proteins in Drosophila
[10] and are involved in neurotransmission as deletion of the
csp gene in Drosophila causes a temperature-sensitive inhibi-
tion of synaptic transmission [11,12]. CSPs are composed of
several conserved domains: the N-terminal domain that contains
a PKA-phosphorylation site implicated in the precise control of
exocytosis in chromaffin cells [13]; the J-domain, highly
homologous to bacterial chaperone DnaJ, interacts with and
stimulates the eucaryotic chaperone Hsc70 [14–16]; the linker
region which according to a point mutation study plays a role in
the function of CSPs in exocytosis [16]; the hydrophobic central
110 F. Boal et al. / Biochimica et Biophysica Acta 1773 (2007) 109–119domain rich in cysteine residues which can be extensively
palmitoylated [17] and the C-terminal domain, which is highly
variable throughout evolution.
Several isoforms have been described with a wide range of
tissue expression in mouse and human [18], Cspα, the first
isoform characterized, plays a central role in mammalian
neurosecretion by regulating calcium channel activity, presum-
ably through its interaction with G proteins [19,20]. Moreover,
in Drosophila Cspα also acts on the regulation of exocytosis by
other means [21].
In insulin-secreting cells, Cspα is localized mainly on
insulin-containing large dense-core vesicles (LDCV) but also
on synaptic-like microvesicles (SLMV) [6]. Cspα has been
shown to be implied in insulin exocytosis as its overexpression
or silencing impairs insulin secretion [6,16,22]. Cspα acts
directly on insulin exocytosis, independently from calcium
transmembrane fluxes [6,23].
Recently, two new predicted isoforms, Cspβ and Cspγ were
described [5], obtained from human and mouse testis cDNA
libraries. It has been shown that Cspβ and Cspγ mRNA are
detected only in testis total mouse mRNA in northern-blot
analysis [24]. So far the functional relevance of the different
isoforms is not known. Does it reflect a location specificity,
each isoform being devoted to defined membrane fusion events
within the cell? Displaying a high sequence homology with
Cspα, the isoform Cspβ can be considered as a natural variant
and therefore constitutes a valuable tool to gain insight on the
cellular function of CSPs. Therefore, we have investigated the
expression of Cspβ in pancreatic β-cell lines and compared its
localization and its biochemical properties to those of Cspα.
When overexpressed in clonal β-cells, Cspβ was mainly
produced as a non-palmitoylated protein tightly bound to
membranes. Furthermore, we found that overexpressed Cspβ
displayed a cellular localization different from Cspα. It was
clearly not associated with LDCV, but rather localized at the
trans-Golgi network. Taking together these results suggest a
correlation between a defined intracellular location of CSPs and
their level of palmitoylation.
2. Materials and methods
2.1. Materials
The following reagents were used: gluthatione-sepahrose 4B (GE Health-
care); isopropyl β-D-thiogalactopyranoside (IPTG), Dnase I, leupeptin hemi-
sulfate, aprotinin, PMSF and pepstatin A (Sigma); Trizol (Invitrogen);
ImProII™ Reverse Transcriptase and Wizard® SV PCR Clean-up System
(Promega). Restriction enzymes and ECL detection kit (Lumi-Light Western
Blotting Substrate) were from Roche Applied Science. The following antibodies
were used: anti-Cspα serum [25]; monoclonal anti-myc (clone 9E10, Sigma);
polyclonal anti-myc (C3956, Sigma); monoclonal anti-myc (clone 4a6, Upstate)
for Figs. 3C and 7); monoclonal anti-insulin (clone K36aC10, Sigma);
monoclonal anti-GST (clone GST-2, Sigma); monoclonal anti-SNAP25
(SMI81, Stemberger Monoclonals Incorporated); monoclonal anti-Hsc70
(clone BRM-22, Sigma); monoclonal anti-β-actin (clone ab276, Abcam);
monoclonal anti-SVP38 (Synaptic Systems GmbH); anti-Vti1b monoclonal
antibody (clone 7, Transduction Laboratories). Polyclonal anti-SGT antibody
was previously described [26]. Monoclonal anti-EEA1 was kindly provided by
Dr. J. Gruenberg [27]. HRP-conjugated secondary antibodies (anti-mouse IgG
or anti-rabbit IgG) and protein A sepharose were from GE Healthcare.Fluorophore-coupled secondary antibodies used in immunofluorescence studies
were from Jackson Laboratories. Protein molecular weight standards were from
Fermentas (unstained), and from BioRad (prestained).
2.2. Molecular cloning and site directed mutagenesis
The plasmids pGEX2T-Cspα and pcDNA3-myc-Cspα were described
previously [22]. The Cspβ sequence was obtained from a human EST (RZPD,
Accession number: AF368276). MycCspβ was obtained by PCR using the
following primers: plus strand 5′-CGCGGATCCATGGCATGTAACATACC-
TAACC-3′ and minus strand 5′-CCGGAATTCGGGACTGTGGACTCTCT-
GAGG-3′; BamHI or EcoRI sites are underlined. PCR products were purified,
digested with BamHI and EcoRI, and inserted into the corresponding sites of a
pcDNA3-myc vector [16] or a pGEX2T vector (GE Healthcare). All constructs,
i.e. pCDNA3-myc-Cspβ and pGEX2T-Cspβ, were verified by double strand
sequencing. The mutants pcDNA3-mycCspα/β1 and pcDNA3-myc-Cspα/β2
were generated by site-directed mutagenesis (Stratagene). First, pcDNA3-
mycCspα was used as the template for generating the α/β1 mutant. The
following sens primer was used, 5′-GGTGGGCCAA(G/A)GC(C/G)CTGTTC-
ATCTTC(TG/GT)TGGGCTCCTCACC(T/G)GCTGCTACT(G/T)TTGCT-
GCTGC-3′ in combination with its antisense primer. The nucleotides in bracket
indicate the bases that were changed to produce amino acid substitutions C113V,
C118G and C121F, according to human sequence comparison (the first
substitution corresponds to a C113I mutation in mouse sequence). The base
substitutions also introduce an additional Eco47III restriction site (underlined
sequence) to allowed simple screening of colonies for mutant plasmids. Second,
the previously obtained pcDNA3-mycCspα/β1 plasmid was used as a template
to generate the α/β2 mutant with the following primers: sense, 5′-CTGCTGC-
TGCT(T/G)CAACTGCTGCTGTGGC(AAG/CAT)TGCAAGCCCAAGG-
CGCC(T/C)GAGGGGGAGG-3′ in combination with its antisens primer. In the
resulting pcDNA3-mycCspα/β2 plasmid, two more mutations were introduced
corresponding to the substitutions F129C and K135H and an additional AvaI
restriction site was introduced for screening (underlined sequence). All these
constructs were double-strand sequenced.
2.3. RT-PCR
Total RNA was prepared using Trizol from fresh mouse brain or cultured
cells according to the manufacturer's instructions and reverse transcribed using
oligo(dT)15 primers and ImProII™ Reverse Transcriptase. Mouse testis cDNA
were kindly provided by Dr. P. Dubus (Bordeaux, France). To amplify the mouse
Cspβ cDNA, we used the following primers designed according to the predicted
sequence (Accession number: AK005749): 5′-ATGGCATGTAACGCACC-
CAACC-3′ and 5′-TTAAGAGTCTGTGCAGTAACTTCGAGATCC-3′.
2.4. Purification of recombinant proteins
E. coli BL21 (DE3) strain (Stratagen) were transformed by pGEX2T vector
containing the coding sequence for Cspα or Cspβ and protein expression was
induced by growing the cells in presence of 0.4 mM IPTG for 3 h at 30 °C.
Bacteria were washed in PBS and resuspended in lysis buffer A [PBS, 5 mM β-
mercaptoethanol, 10 mMMgCl2, 1 mMATP, 1% TritonX-100, 10 U/ml Dnase I,
protease inhibitors (apoprotinine, leupeptine, pepstatine A 1 μg/μl each and
0.1 mM PMSF) final pH 8] and passed twice through a French-Press (Carver,
25,000 psi). Bacterial extracts were clarified by centrifugation (20,000×g, 1 h
4 °C) and GST-fusion proteins were recovered from the supernatants by binding
to glutathione-sepharose beads according to manufacturer's instructions (GE
Healthcare-Amersham Biosciences). Recombinant proteins were over 95% pure
as judged by Coomassie blue stained SDS-PAGE.
2.5. GST-pull down experiments
MIN6 cells were washed with PBS, detached by incubation in PBS-10 mM
EDTA (15 min at 37 °C), recovered by centrifugation and washed once with
PBS prior to be resuspended in homogenate buffer B [20 mM MOPS (pH 7),
250 mM sucrose, 4.5 mM MgCl2, 10 μg/ml orthovanadate and protease
inhibitors as in buffer A). Cells were lysed at 4 °C first by sonication (6 times
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homogenate was clarified by centrifugation (1000×g for 5 min at 4 °C) and
protein concentration in the resulting lysate was quantified (Bradford Biorad
Protein Assay, Biorad). For each binding experiment, MIN6 homogenate
aliquots (500 μg of proteins) were first treated extemporary with 0.5% (w/v)
Triton X-100 (60 min, 4 °C). After centrifugation (20,000×g 5 min 4 °C)
supernatants were recovered. These supernatants were diluted in binding buffer
C [20 mMMOPS (pH 7), 5 mMMgCl2, 200 mMNaCl) in order to dilute Triton
X-100 down to 0.1% (w/v). Then 25 μg of recombinant GST proteins were
added (GST, GST-Cspα or GST-Cspβ). After incubation at 4 °C for 2 h, 40 μl of
glutathione-sepharose beads (equilibrated in buffer C) were added and
incubation was continued for 2 h. Beads were recovered by centrifugation and
washed 3 times with 20 bead volumes of buffer C supplemented with 0.1%
Triton X-100 and once with 20 bead volume of Buffer C alone prior to be
resuspended in SDS-PAGE sample buffer (2% (w/v) SDS, 8% (v/v) β-
mercaptoethanol, 10% (w/v) glycerol, 50 μg/ml bromophenol blue, 50 mM Tris
pH 6.8). One third of each resulting samples was applied on 10% SDS-PAGE,
transferred to PVDF membrane and analyzed by Western-blotting. Prior to
immunoblotting membranes were stained with Coomassie blue to assess that an
equivalent amount of recombinant GST proteins was recovered for each condi-
tions (not shown).
2.6. Cell culture, transfection, immunofluorescence and metabolic
labeling
Cell culture and transfections were performed as described [16,22]. For
immunofluorescence studies, cells were fixed with paraformaldehyde 3 days
after transfection as described [22,28] and incubated with the following
antibodies: anti-myc 1/500, anti-insulin 1/100, anti-SVP38 1/200, anti-EEA1 1/
100, and anti-Vti1b 1/500. Fluorophore-coupled second antibodies were used at
a dilution of 1/500 (anti mouse IgG Cy3-coupled and anti rabbit IgG FITC-
coupled antibodies). Imaging was performed on a LMS 510 Meta confocal laser
microscope (Zeiss). For metabolic labeling, HIT-T15 were transfected with
pCDNA3-myc-Cspα or pCDNA3-myc-Cspβ in culture medium supplemented
with 2% FBS, 5 mM sodium pyruvate and 200 μCi/ml [3H]-palmitic acid
(5 mCi/ml; PerkinElmer Life Sciences). After overnight transient overexpres-
sion, labeled cells were washed twice with ice-cold PBS and resuspended in
RIPA buffer [50 mM Tris; 5 mM EGTA; 150 mM NaCl; 0.1% SDS; 0.5%
deoxycholate; 1% Nonidet P40; leupeptin/aprotinin/pepstatin A 1 μg/ml; pH
7.5]. After a 30 min incubation cell homogenization was achieved by 10
passages through a 27 Gauge needle and insoluble materials were removed by
centrifugation at 10,000×g for 10 min at 4 °C. For immunoprecipitation,
samples were incubated overnight at 4 °C with anti-myc polyclonal antibody
immobilized onto protein A sepharose beads or protein A sepharose beads alone.
Beads were extensively washed and bound materials were loaded onto SDS-
PAGE. Immunoprecipitated proteins were revealed by immunoblotting with a
monoclonal anti-myc antibody or by autoradiography on a BioMax MS film
(PerkinElmer Life Sciences) exposed for 4 weeks.
2.7. Subcellular fractionation and chemical treatments
HIT-T15 cells were treated 3 days after transfection. Cells were washed with
PBS, then detached with PBS-10 mM EDTA at 37 °C, centrifuged 5 min at
300×g and 4 °C. Cell pellets were resuspended in Buffer C [20 mM HEPES (pH
7.4), 5 mMMgCl2, 100 mM KCl, protease inhibitors as in buffer A]. Cells were
lysed by sonication (Sonicator XL2020 Misonix, 6 time 10 s pulses, level 2).
Cell extracts were clarified by centrifugation (2000×g, 5 min 4 °C) to obtain a
post-nuclear supernatant (PNS). Membranes (M) and cytosol (C) were separated
by centrifugation at 20,000×g for 1 h at 4 °C. For NH2OH treatment, an aliquot
of the PNS was mixed with 1 volume of 2 M NH2OH (pH 8) or 1 volume of 2 M
Tris (pH 8) as control. After 12 h incubation at 4 °C, reaction mixtures were
immediately analyzed by Western-blotting.
Membrane association tests were assayed by mixing PNS aliquots and the
following buffers (final concentrations): Buffer C or 1 M NH2OH (pH 8) or 1 M
NaCl or 1 MNH2OH combined with 1 M NaCl or 0.2 MNa2CO3 (pH 11) or 1%
Triton X-100. After incubation for 10 h at 4 °C, samples were centrifuged for
90 min at 20,000×g. Pellets were resuspended in 50 μl SDS-PAGE sample
buffer, and analyzed by Western-blotting after SDS-PAGE. Membraneassociation was estimated by quantification of the signals present in each pellet
fraction and expressed as a percentage of the control condition (PBS treatment).
Results are presented as means±SEM.
2.8. Membrane attachment of recombinant proteins
For membrane attachment experiments, HIT-T15 cells were homogenized
by sonication in Buffer D (10 mM Tris (pH 7), 150 mM NaCl, 0.32 M Sucrose,
4 mM EDTA, and protease inhibitors as in Buffer A). Cell debris were pelleted
by centrifugation (5 min 1000×g 4 °C) and the protein amount in resultant post-
nuclear supernatant (PNS) were quantified by Bradford reaction. Binding assays
were performed in 500 μL final volume by mixing recombinant GST proteins
(from 2 nM to 310 nM) with 20 μg of PNS for 2 h at 4 °C under constant
agitation. Membranes and membrane associated proteins (bound) and
supernatant (unbound) were separated by centrifugation (1 h, 20,000×g,
4 °C). Pellets were either washed three times in buffer D and solubilized directly
in SDS-PAGE sample buffer or were resuspended in buffer D or 0.2 M Na2CO3,
incubated for 2 h and centrifuged again (1 h, 20,000×g, 4 °C). Resulting pellets
were resuspended in SDS-PAGE sample buffer. Proteins were separated on a
12% SDS-PAGE, transferred onto a PVDF membrane. GST, GST-Cspα and
GST-Cspβ were stained with an anti-GST antibody. Images were quantified as
described before [22].
2.9. In-silico prediction of Csp membrane domains
The TMHMM program (http://www.cbs.dtu.dk/services/TMHMM) was run
on human sequences as Cspβ has not been cloned from other species. More
detailed thermodynamic calculations were obtained employing MPex (version
3; http://blanco.biomol.uci.edu/mpex/) assuming the absence of β-sheets, using
a final window size of 24, a helicity value set to 0 and no salt bridges were
introduced.3. Results
3.1. Cspβ interacts with the chaperone complex Hsc70/SGT in
MIN6 cells
Cspα and Cspβ are highly similar according to the sequence
alignment (Fig. 1A). They exhibit 66% overall amino-acid
identity. However, looking closely to homology between each
domain, some differences can be noted. For instance the N-
terminus differs, particularly by the presence of a short
extension in Cspβ, whereas the J-domain and the linker region
are largely conserved (75% and 82% identity, respectively). The
cysteine-rich domains are similar (80%) and the C-terminal
domains constitute the most variable part exhibiting only 45%
identity.
Cspα is known to be part of a trimeric complex including
Hsc70 and the cognate regulatory protein SGT [8,9]. In a first
attempt to compare Cspα and Cspβ, we resorted to pull-down
experiments in insulin-secreting MIN6 cells. GST alone, GST-
Cspα or GST-Cspβwere immobilized on gluthatione-sepharose
beads, incubated with homogenates of MIN6 cells, washed
extensively and bound proteins were eluted and loaded on SDS-
PAGE. First, Cspα interacts in MIN6 extracts with Hsc70/SGT,
suggesting a relevant implication of this complex in insulin
secretion (Fig. 1B). Second, regarding the homology between
the two J-domains, we investigated the ability of Cspβ to recruit
this complex. GST-Cspβ was able to bind both Hsc70 and SGT
to the same extent as GST-Cspα (106±11% and 99±22%
respectively, compared to Cspα, n=3). Thus, Cspβ can recruit
Fig. 1. The Cspβ isoform is able to recruit both Hsc70 and SGT. (A) Sequence comparison between mouse Cspα and Cspβ. Mouse Cspα protein sequence and
predicted sequence for mouse Cspβ are depicted. Identical residues are shaded in dark grey whereas similar residues are colored in light grey. Gaps inserted are
represented by ‘−’. The different domains are indicated by arrows above sequences. (B) Cspβ interacts with Hsc70 and SGT. MIN6 cell extracts were incubated with
either gluthatione-sepharose beads are with beads coated with GST, GST-Cspα or GST-Cspβ. Thirty percent of bound proteins and 0.5% of the extract (Input) were
immunoblotted with antibodies raised against Hsc70 and SGT as indicated. The data are representative of three separate experiments.
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similar extent as Cspα, excluding therefore a role of the less
conserved C-terminus domain in the formation of the trimeric
complex.
3.2. Endogenous expression of Cspβ in insulin-secreting cells
Next we addressed the question of Cspβ expression in β-
cells using RT-PCR. Since only mouse and human sequences
are known, we used primers designed specifically for mouse
Cspβ sequence. We investigated the presence of Cspβ in cDNA
preparation obtained from MIN6 mouse cell line and from
mouse brain. Mouse testis cDNA preparation was used as
positive control since the original EST was obtained from a
testis library. According to the actin amplification control, thecDNA concentration in this control template is lower than in the
other ones. Nevertheless, an amplification signal displaying the
expected size of 600 bp for Cspβ could be obtained with this
cDNA template (Fig. 2). On the other hand no amplification
signal was obtained using mouse brain or MIN6 cells templates.
This is consistent with previous northern-blot studies showing
that Cspβ mRNA was only detected in mouse testis [24]. Our
data suggest that Cspβ is not expressed in the β-pancreatic cell
line MIN6.
3.3. Overexpressed Cspβ is mainly non-palmitoylated but
tightly bound to membranes
Since Cspβ was not expressed in insulin-secreting cells,
overexpression of myc-tagged CSPs in such cells allowed
Fig. 2. Cspβ cDNA is present according to RT-PCR in testis but not in brain nor
in the insulin secreting MIN6 cell line. MIN6 cells, mouse brain or mouse testis
cDNAwere amplified with specific primers for mouse Cspβ (upper panel) or β-
Actin (lower panel). Specific amplification of a band displaying the expected
size of 600 bp was only achieved with testis cDNA.
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MIN6 cells only very low expression rates of mycCspβ could
be achieved (data not shown). For this reason we used the
hamster insulinoma HIT-T15 cells, in which transient transfec-
tion is more efficient and overexpressed Cspα has been shown
to be properly targeted within these cells [22]. We investigated
Cspβ distribution by Western-blot analysis after cellular
fractionation into cytosolic and membrane fractions. Both,
overexpressed mycCspβ and mycCspα, were mainly found as a
membrane associated proteins (Fig. 3A). According to the
primary sequence, mycCspα protein should display a molecular
weight of 30 kDa and post-translational modifications such asFig. 3. Transiently expressed Cspβ is mainly non-palmitoylated in β-pancreati
overexpressing mycCspα or mycCspβ. Post-nuclear supernatant (PNS), membrane (M
with an anti-myc antibody. Molecular mass markers are indicated in kilodaltons. (B) T
not (−) with NH2OH to cleave palmitoylation modifications. (C) Metabolic labelin
incubated with [3H]-palmitic acid and solubilized proteins were immunoprecipitated
with protein A sepharose alone (−). After washing bound proteins were analysed by S
of the input (Input) were loaded and later on submitted to immunoblotting with a mo
other part of the gel (right panel), two third of bound proteins were analyzed by autora
in kilodaltons. Palmitoylated forms of mycCspα and mycCspβ are indicated by a cpalmitoylations raise the apparent molecular weight up to
∼38 kDa as described previously [16,22] (Fig. 3A, lane 1,
upper band). Consequently, overexpressed mycCspβ was
detected as three different species (Fig. 3A, lane 1). The
major band with an apparent molecular weight of ∼30 kDa
most probably corresponded to a non-palmitoylated form. The
minor band at ∼33 kDa probably correspond to a partially
palmitoylated protein (see below). The band at ∼65 kDa
observed upon overexpression of mycCspβ could correspond to
a dimeric form of the overexpressed protein as previously
observed for Cspα [22].
To investigate the level of palmitoylation of these proteins,
we used hydroxylamine (NH2OH) which is known to cleave
such modifications, resulting in a decrease of the apparent
molecular weight of the protein as previously observed for
Cspα [16,17]. Indeed, upon treatment with NH2OH, mycCspα
was mainly detected as a ∼30 kDa band (Fig. 3B lane 2). The
minor band of ∼33 kDa could correspond to a partially
depalmitoylated form, since it was more predominant with
shorter NH2OH treatments (data not shown) and in agreement
with previous study [17]. When cell extracts containing
mycCspβ were treated with NH2OH, the minor band of
∼33 kDa disappeared (Fig. 3B lane 4) and therefore represented
probably a partially palmitoylated monomeric form. The major
∼30 kDa band was not affected by this treatment according toc HIT-T15 cells. (A) Subcellular fractionation of HIT-T15 cells transiently
) and cytosolic (C) fractions were submitted to SDS-PAGE and immunoblotted
otal cell extracts from cells expressing mycCspα or mycCspβwere treated (+) or
g of HIT-T15 cells transiently expressing mycCspα or mycCspβ. Cells were
with a polyclonal anti-myc antibody coupled to protein A sepharose beads (+) or
DS-PAGE. On one part of the gel (left panel), one third of bound proteins and 5%
noclonal anti-myc antibody after transfer onto PVDF membrane (Blot). On the
diography ([3H]-palmitate). Molecular weight of prestained markers are indicated
ircle and an arrow-head, respectively.
Fig. 4. Transiently expressed Cspα and Cspβ behave like intrinsic membrane
proteins. (A) Membrane association of mycCspα and mycCspβ was assayed
by indicated treatments. After treatments, samples were centrifuged and the
same amount of each membrane fractions (volume to volume) were
immunoblotted with an anti-myc antibody to reveal myc-Cspα and myc-
Cspβ and with an anti-SNAP25 antibody. (B) Membrane association of
mycCspα, mycCspβ and SNAP25 after chemical treatments was quantified
and expressed as percentage of each protein present in the PBS treated
resulting pellet. Results are presented as means±SEM, n=3. An asterisk
means p<0.003 as compared to PBS treatment.
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to a non-palmitoylated form. To confirm these hypotheses,
transfected cells were incubated with [3H]-palmitic acid and
overexpressed proteins were immunoprecipitated with anti-myc
antibodies after labeling. After immunoprecipitation, both
38 kDa and 30 kDa bands were revealed by western-blot for
mycCspα containing extracts but only the 38 kDa band was
detected upon autoradiography and thus corresponded indeed to
a palmitoylated form whereas the other one did not (Fig. 3C).
By the same way, both the major 30 kDa and the minor 33 kDa
bands were efficiently immunoprecipitated from mycCspβ
containing extracts but only this later one was detected upon
autoradiography and therefore corresponded to a partially
palmitoylated form. The predominant 30 kDa band present in
mycCspβ extracts was clearly not detected upon autoradiogra-
phy (Fig. 3C). In conclusion, overexpressed mycCspβ is
predominantly produced as non-palmitoylated form in HIT-T15
cells and is associated with the membrane fraction.
Palmitoylation of CSPs is believed to be implicated in the
stable association of CSPs with membranes [16,17,29,30].
Treatments with several chemicals were done to test the
membrane association of mycCspβ and compared to their
effects on the membrane association of mycCspα. NH2OH
treatment which removes palmitoyl groups from cysteines is not
able to detach mycCspα and mycCspβ from the membrane
pellets (Fig. 4A), with 104±11% and 87±4% remaining
membrane bound after such a treatment (Fig. 4B). As a control
we determined the behavior of endogenous SNAP25, a
hydrophilic protein bound to membranes via four palmitoylated
cysteine residues [31]. SNAP25 was stripped off from the
membrane fraction by such a treatment (Fig. 4A and B). Other
treatments, such as high ionic stringency (1 M NaCl) or
combined NH2OH/high ionic strength treatment did not
displace significantly any of the CSP isoforms from the
membrane fractions, whereas membrane associated β-actin
used as a control was detached from membranes by such
treatments (data not shown). As reported before [29], sodium
carbonate treatment, known to release peripheral membrane
proteins [32], was not able to displace mycCspα from mem-
branes (Fig. 4A and B). In contrast, SNAP25 was efficiently
removed from the membrane pellet by this treatment. MycCspβ
was only partially stripped off by sodium carbonate treatment
with 62±2% remaining membrane associated. Complete
solubilization of mycCspα and mycCspβ from membranes
was only achieved after Triton X-100 treatment. Thus, both
mycCspα (palmitoylated or not) and mycCspβ (non-palmitoy-
lated) expressed in β-pancreatic cell lines behave like integral
membrane proteins.
3.4. Unmodified recombinant Cspα and Cspβ bind to cellular
membranes
It has been proposed that palmitoylation itself is not strictly
required for stable membrane association but is rather essential
for initial targeting of the protein to the vesicle membranes [33].
We therefore first evaluated in-silico the propensity of Csp to
distribute into the lipid bilayer. The TMHMM program (http://www.cbs.dtu.dk/services/TMHMM) predicts a membrane do-
main between A108 and N130 in CSPα and between A112 and
C133 in CSPβ. Further analysis using MPEx [34] indicates that
these domains indeed have a propensity to move from the
aqueous environment to the interface (ΔG −10.3 and −11.2 kJ/
mol for Cspα and Cspβ, respectively). However, calculation of
the interface/octanol values for these hydrophobic domains,
which reflects the tendency to insert fully into the hydrophobic
core of the membrane, revealed values for ΔG of −0.1 and
−0.9 kJ/mol only. For comparison, the corresponding values
obtained for the known transmembrane domains of the SNARE
proteins VAMP2 or syntaxin 1 are −9.8 and −6.6 kJ/mol. Helix-
wheel drawing did not reveal any obvious amphipathy. These
calculations suggest that Cspα and β are membrane embedded
but do most likely not traverse the lipid bilayer.
To assess in-vitro the respective role of palmitoylation and
intrinsic properties of CSPs in terms of membrane association,
we investigated the ability of recombinant GST-CSPs to bind to
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are non-palmitoylated and the assay is therefore not influenced
by lipidation. Incubation of recombinant GST-Cspα or GST-
Cspβ protein with freshly prepared cellular homogenates (PNS)
at 4 °C resulted in a saturable association with membrane
fraction with an EC50 of approx. 18 nM for Cspα and 10 nM for
Cspβ (Fig. 5). This association did not occur with GST alone
and less than 10% of GST-Csp was recovered in the absence of
PNS. Therefore attachment to PNS membranes is mediated by
the intrinsic properties of CSPs. This result indicated that
palmitoylation of CSPs was not required for membrane
association and corroborates our previous data obtained from
overexpression of Cspβ in clonal β-cells. However, after in
vitro binding of recombinant proteins to membranes, both GST-
Cspα and GST-Cspβ were partially stripped off from
membranes by sodium carbonate treatment but not by buffer
alone (data not shown). This indicated that the attachment
obtained in vitro was weaker than the ones observed in trans-
fected cells.
3.5. Subcellular localization of overexpressed Cspβ
We next asked whether the behavior of mycCspβ in term of
post-translational modifications and membrane association may
be linked to a particular subcellular localization within the cells.Fig. 5. Recombinant non-palmitoylated GST-Cspα and GST-Cspβ can bind to
membranes. Recombinant GST-Cspα, GST-Cspβ or GST alone was mixed at
indicated concentration with freshly prepared cellular post-nuclear supernatant
(PNS). After 2 h incubation at 4 °C, cellular membranes and associated proteins
(Bound material) were pelleted by centrifugation, extensively washed and
solubilized. The amount of recombinant proteins bound to membranes was
analyzed by Western-blot using an anti-GST antibody and quantified (upper
panel). Bound on unbound material was plotted against recombinant protein
concentrations used in each binding assay (lower panel). The EC50 was
estimated to be about 18 nM for GST-Cspα and about 10 nM for GST-Cspβ
(calculated by the program Origin v.6.1). These data are representative of three
independent experiments.Therefore, the subcellular localization of overexpressed
mycCspβ was investigated in comparison to mycCspα in
HIT-T15 cells by immunofluorescence. Cspα and overex-
pressed mycCspα are mainly addressed to LDCV in pancreatic
β−cells ([6,16,23] and Fig. 6A). MycCspβ displayed a specific
granular staining, but clearly did not co-localize with insulin-
containing granules (Fig. 6B). As Cspα localizes also on
synaptic-like microvesicles (SLMV) [6], we examined whether
the same applies for Cspβ using SVP38/Synaptophysin as a
marker for this compartment. We could not find any co-
localization between mycCspβ and SVP38, or with EEA1
(early endosomal antigene 1) (data not shown), indicating that
mycCspβ was not localized on these organelles. However, co-
staining with an antibody against Vti1b, a marker for the trans-
Golgi network (TGN) and derived vesicles [35,36] clearly
revealed that overexpressed mycCspβ was mainly found within
or adjacent to the TGN (Fig. 6D). In contrast, co-localization
with Vti1b was not observed in the case of mycCspα (Fig. 6C).
Thus mycCspβ, despite its wide sequence homology with
Cspα, displayed a specific sub-cellular localization in HIT-T15
cells distinct from Cspα.
In a first attempt to characterize the molecular basis of the
differential behavior between Cspα and Cspβ in terms of
palmitoylation and targeting, we looked more closely to the
sequence features within the two cysteine string domains as-
suming that a slight sequence difference could be critical for the
initiation of the post-translational modifications [37]. For
instance the following residues in cysteine core of Cspα cys-
teine are different in Cspβ: C113, C118, C121, F129 and K135
(Fig. 7A). We created a first Cspβ-like Cspα mutant called
Cspα/β1 by site directed mutagenesis corresponding to the
following substitutions in the N-terminal part of the Cspα
cysteine string domain: C113V, C118G and C121F. A second
Cspα mutant, Cspα/β2, was created with two additional sub-
stitutions in the C-terminal part: F129C and K135H. When
expressed in HIT-T15 cells, both myc-tagged Cspα/β1 and
Cspα/β2 displayed the same electrophoretic mobility as Cspα
with an apparent molecular weight of ∼38 kDa. This indicates
that the introduced modifications did not alter the extensive
palmitoylation process. Both mutants were also membrane
associated (Fig. 7B). In addition, the mutations introduced in
mycCspα/β1 (not shown) and mycCspα/β2 did not alter the co-
localization with insulin granules (Fig. 7C). Thus, these five
residues which are specific to the cysteine string domain of
Cspα as compared to Cspβ are not essential for proper
palmitoylation and targeting of Cspα. The difference between
the two proteins resides therefore somewhere else within the
sequence.
4. Discussion
CSPs are synaptic vesicle and secretory granule associated
proteins. The isoform Cspα has a major role in exocytosis,
mainly by regulating calcium channel activity in neurosecre-
tion and also by acting directly on insulin secretion in β-
pancreatic cells independently from ion channel regulation
[6,23]. Several different isoforms have been described and
Fig. 6. Transiently expressed Cspβ is located on the trans-Golgi network in clonal β-cells. Immunofluorescence studies were performed on HIT-T15 cells transiently
expressing mycCspα (A and C) or mycCspβ (B and D) as indicated. Cells were doubled-stained with a polyclonal anti-myc antibody revealed by a FITC-coupled
secondary antibody (green channel, “myc”) and with either a monoclonal anti-insulin antibody (red channel, “insulin”) or with in a monoclonal anti-Vti1b antibody
(red channel, “Vti1b”) revealed by a Cy3-conjugated antibody. Images were acquired using a confocal laser microscope. Phase contrast, green and red channels and
overlay images are shown. Colocalization results in yellow. Bar size equals to 10 μm.
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this study, we compared two CSP isoforms, Cspα, the first one
described in the literature [10] and the newly described from
testis cDNA library, Cspβ [24]. Regarding the heterogeneity of
cell types composing the testis and the variations between
primary cells and the available tumor cell lines, we resorted to
transient expression of both isoforms in pancreatic β-cell
derivative cell lines, a cell system in which Cspα has been
previously characterized in term of location, interactions and
post-translational modifications.
As shown here, Cspα interacts with the Hsc70/SGT
chaperone complex also in endocrine cells, a complex
previously identified as functionally relevant in neurosecretion
[8]. It is thus likely that the trimeric Csp/Hsc70/SGT complex
intervenes not only in exocytosis of synaptic vesicles, but also
during exocytosis of large dense core vesicles such as insulin-
containing secretory granules. The J-domain of Cspα has been
reported to support most of its interaction with Hsc70
[14,15,38]. Our finding that Cspβ interacts to a comparable
extent with Hsc70 further strengthens the role of the J-domain in
this interaction in view of the very high sequence homology
between Cspα and Cspβ within this domain. Moreover, pull-
down experiments using Cspα or Cspβ recovered similar
amounts of SGT. Direct interaction of Cspα with SGT is mainly
mediated by its cysteine string region which is indeed wellconserved between the two isoforms [9]. As the C-terminus
domain of CSPs is the less conserved domain, the formation of
the trimeric Csp/Hsc70/SGT complex does probably not require
the latter domain.
Cspβ was not expressed in MIN6 cells according to our RT-
PCR analysis. Since specific antibodies are not available for this
isoform, we used myc tagged Cspβ to compare this isoform
with Cspα in insulin-secreting cell lines. Two main features
were observed. First, unlike mycCspα, mycCspβ is mainly
produced as a non-palmitoylated form. According to previous
studies, Cspα is no longer able to interact in vivo with
membranes when cysteine residues are replaced by serine
residues [33]. However it is difficult to conclude if this mis-
targeting results from the absence of palmitoylation or from the
replacement per se of hydrophobic residues, such as the
cysteines. The persistent membrane attachment observed for
mycCspβ strongly indicates that the establishment of a tight
membrane association does not require an extensive palmitoy-
lation of cysteine residues within CSP proteins in vivo. It should
be noticed that even though mycCspβ was lacking extensive
palmitoylations as shown by metabolic labeling here, it was
only partially displaced from membranes by sodium carbonate
treatment. It is therefore likely that membrane anchoring of both
mycCspα and mycCspβ is not solely based on posttranslational
acylation of cysteine residues but also relies on intrinsic
Fig. 7. Sequence differences between Cspα and Cspβ within the cysteine string
domain itself are not responsible of differences in palmitoylation and targeting.
(A) Sequence comparison of residues 104 to 136 of Cspα, Cspβ and of Cspα/β1
and Cspα/β2 mutants. Amino acid substitutions introduced in Cspα are
indicated in bold. (B) HIT-T15 cells transiently expressing mycCspα/β1 or
mycCspα/β2 were treated as in Fig. 3A. MycCspα and mycCspβ proteins
expressed under the same conditions were used as electrophoretic mobility
markers. (C) Immunofluorescence studies of HIT-T15 cells transiently
expressing mycCspα/β2. Cells were doubled-stained as in Fig. 6.
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membrane domain predictions and thermodynamic calcula-
tions, both CSPs contain a hydrophobic domain including the
cysteine-string but which has not a strong propensity to fully
translocate into the hydrophobic core itself. This in-silico
assessment is strengthened by the results obtained using
recombinant CSP isoforms produced and purified from
bacteria, thus without any palmitoylation. They were still
able to interact rather efficiently with HIT-T15 cell membranes
in vitro at 4 °C but were not fully embedded in membranes
according to the sensitivity to sodium carbonate. Therefore in-
silico and in-vitro data suggest the presence of additionalfactors in-vivo promoting the insertion into the hydrophobic
core such as energy, a specific machinery or folding of the
hydrophobic domain that may not be fully attained by the
recombinant protein.
Second, we have shown here that mycCspβ displayed a
different intracellular localization than either endogenous Cspα
or overexpressed mycCspα since it clearly did not co-localize
with LDCVs, the insulin containing granules. MycCspβ rather
co-localized with Vti1b, a known marker for the TGN and
derived vesicles [35,36]. Even though Cspβ and Cspα display a
high degree of sequence homology within the cysteine string
domain, a slight difference could be critical for the initiation of
the post-translational modification [37]. Regarding sequence
differences between Cspα and Cspβ within their cysteine string
domains five residues were pointed out (i.e. Cspα residues
C113, C118, C121, F129 and K135). The systematic replace-
ment of these residues in Cspα by their counterparts in Cspβ did
not affect palmitoylation and targeting of the so obtained
mycCspα/β2 protein. Thus, the specific targeting of Cspβ and
its non-palmitoylated state is not supported by these specific
residues and therefore resides elsewhere than in the cysteine
string. Cspα and Cspβ differ in several parts of their sequence.
The distinct N-termini can be excluded as responsible for
differences in palmitoylation and targeting as N-terminally
truncated Cspα is posttranslationally modified and targeted as
full-length Cspα. The extreme C-termini (after residue 168 in
Cspα) are also unlikely to play a role here as both splice variants
of Cspα, varying only in this part of the sequence, are
palmitoylated similarly and targeted to the same compartments
[16,22]. The main remaining difference is located just C-
terminally to the cysteine string. Indeed, comparing several
species a short divergent stretch is evident between residues 137
and 147 (according to Cspα) containing five changes, three
being non-conservative, and one omission. This divergence
might represent a signal for targeting to an organelle harboring
the palmitoyl-transferase or a site required for the interaction of
Csp with the enzyme.
It is indeed tempting to correlate the lack of extensive post-
translational modifications of Cspβ and its specific location
within the Golgi apparatus. One may consider that palmitoyla-
tion could be either necessary to reinforce the interaction with
membranes or to assist in the targeting/retention of the protein
to a specific intracellular compartment. Subsequently the lack
of extensive palmitoylation on Cspβ could interfere with its
targeting to LDCVs. Such a model was proposed for the
proper trafficking of huntingtin protein as palmitoylation was
a requisite to exit the Golgi apparatus [39]. Alternatively,
palmitoylation may occur subsequent to targeting as it has
been proposed for the t-SNARE SNAP25 where this
modification occurs after targeting to plasma membrane and
depends on the interaction with another protein, i.e. syntaxin 1
[40].
Our data stress the relevance of Cspβ as a tool to investigate
not only the behaviour of CSPs in insulin secreting cells but also
to examine more generally the functions of CSPs, particularly
regarding the possible correlation between targeting and
palmitoylation level. It has been recently proposed that Hsc70
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taking place during ER to Golgi transport possibly via an
interaction with the specific ER/Golgi SNAREs. [41]. Hsc70
like any other DnaK proteins can be considered as general
folding catalyst which performs tasks requiring a DnaJ like
partner to recruit a specific target substrate at a defined location,
to activate its ATPase activity and to recycle the chaperone [42].
Distinct protein–protein interactions via their variable C-
terminus, as had been described for the splice variants 1 and 2
of Cspα [22], and different post-translational modifications, as
shown here, may contribute to the specificity of CSP isoforms
in distinct membrane fusion events.
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